Treatment of gastrointestinal cytomegalovirus infection with twice-daily foscarnet: a pilot study of safety, efficacy, and pharmacokinetics in patients with AIDS.

Ten patients with AIDS and cytomegalovirus (CMV) gastrointestinal infection were included in an open-label study to evaluate the safety, efficacy, and pharmacokinetics of 90 mg of intravenous foscarnet/kg of body weight twice daily accompanied by (pre)hydration of 500 to 750 ml. Efficacy was documen...

Fuld beskrivelse

Bibliografiske detaljer

Udgivet i:	Antimicrob Agents Chemother
Principais autores:	Dieterich, D T, Poles, M A, Lew, E A, Martin-Munley, S, Johnson, J, Nix, D, Faust, M J
Format:	Artigo
Sprog:	Inglês
Udgivet:	American Society for Microbiology (ASM) 1997
Fag:	Research Article
Online adgang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163891/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9174175/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.6.1226
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!